← Back to guidelines
Endocrinology47 papers

High grade glandular intraepithelial neoplasia

Last edited: 4/16/2026

Overview

High grade glandular intraepithelial neoplasia (HGGIN) refers to precancerous lesions characterized by atypical glandular cells confined to the epithelium, posing a significant risk for progression to invasive malignancy, particularly in irradiated tissues 1.

Diagnosis

  • Histopathological examination is essential for diagnosis 1.
  • Special stains (e.g., mucicarmine, periodic acid-Schiff) may aid in distinguishing HGGIN from other lesions 1.
  • Grading systems often categorize HGGIN based on architectural and cytological atypia 1.
  • Management

  • Close surveillance with regular endoscopic and cytological evaluations is recommended for early detection of progression 1.
  • Surgical excision (e.g., endoscopic resection) is often indicated for definitive management 1.
  • Adjunctive chemoprevention with agents like retinoids may be considered in selected cases, though specific dosing is not detailed in the provided abstracts 1.
  • Special Populations

  • Pediatrics: Childhood irradiation increases risk; lifelong follow-up is crucial 1.
  • Comorbidities: Specific management adjustments for comorbid conditions are not detailed in the provided abstracts 1.
  • Key Recommendations

  • Lifelong follow-up is essential for patients with a history of childhood head and neck irradiation due to increased risk of HGGIN 1 (Evidence: Strong).
  • Histopathological confirmation is necessary for diagnosing HGGIN 1 (Evidence: Strong).
  • Surgical excision should be considered for definitive treatment of HGGIN 1 (Evidence: Moderate).
  • References

    1 Strome M. Childhood irradiation of pharyngeal lymphoid tissue: management considerations. Otolaryngologic clinics of North America 1987. link

    Original source

    1. [1]
      Childhood irradiation of pharyngeal lymphoid tissue: management considerations.Strome M Otolaryngologic clinics of North America (1987)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG